Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02981329 · ClinicalTrials.gov registry record · Early Phase 1
Fetal Hemoglobin Induction Treatment Metformin
A Early Phase 1 study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 37
- Enrollment target
NCT02981329 is a Early Phase 1 study that has completed, run by Baylor College of Medicine. The registered enrollment target is 37 participants.
The verdict
NCT02981329, a Early Phase 1 study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 37 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether metformin is effective in the treatment for sickle cell anemia (SCA).
Interventions
- DRUG Metformin
- BEHAVIORAL Questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2017-03-02 |
| Est. Completion | 2020-07-20 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02981329
The ClinicalTrials.gov registry entry for NCT02981329 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Metformin is the first listed.
NCT02981329 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02981329 about?
NCT02981329 is a clinical study titled "Fetal Hemoglobin Induction Treatment Metformin". The purpose of this study is to determine whether metformin is effective in the treatment for sickle cell anemia (SCA).
What is the current status of trial NCT02981329?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 37 participants. The study started on 2017-03-02. Estimated completion is 2020-07-20.
What interventions are being tested in trial NCT02981329?
The interventions under investigation include: Metformin (DRUG), Questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT02981329?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.